Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
China · Delayed Price · Currency is CNY 28.68
+0.13 (0.46%)
Jul 31, 2026, 3:00 PM CST
SHA:688062 Market Cap
SHA:688062 has a market cap or net worth of 12.28 billion as of July 31, 2026. Its market cap has decreased by -7.50% in one year.
Market Cap
12.28B
Enterprise Value
14.24B
Revenue
745.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
28.68
ChartMarket Cap Chart
Since January 18, 2022, SHA:688062's market cap has increased from 9.79B to 12.28B, an increase of 25.43%. That is a compound annual growth rate of 5.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 12.28B | -20.08% |
| Dec 31, 2025 | 15.36B | 90.35% |
| Dec 31, 2024 | 8.07B | -38.21% |
| Dec 29, 2023 | 13.06B | 126.23% |
| Dec 30, 2022 | 5.77B | -41.02% |
| Jan 18, 2022 | 9.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BrightGene Bio-Medical Technology | 14.60B |
| Anhui Anke Biotechnology (Group) | 13.69B |
| InventisBio | 13.33B |
| Jinyu Bio-technology | 12.62B |
| Inner Mongolia Furui Medical Science | 11.81B |
| Tibet Cheezheng Tibetan Medicine | 11.72B |
| HitGen | 11.52B |
| Chengzhi | 11.03B |